The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease

David I. Finkelstein(The University of Melbourne), Robert A. Cherny(The University of Melbourne)
Acta Neuropathologica Communications
June 28, 2017
Cited by 99


Related Papers